Sun Pharma Advanced Research Company Ltd vs Vista Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Sun Pharma Advanced Research Company Ltd is ₹ 162.15 as of 18 May 15:30 . The P/E Ratio of Sun Pharma Advanced Research Company Ltd is 0 as of March 2023 .The P/E Ratio of Vista Pharmaceuticals Ltd is 0 as of March 2023 . The Market Cap of Sun Pharma Advanced Research Company Ltd is ₹ 5823 crore as of March 2023 .The Market Cap of Vista Pharmaceuticals Ltd is ₹ 0 crore as of March 2023 . The revenue of Sun Pharma Advanced Research Company Ltd for the Mar '26 is ₹ 1855 crore as compare to the Dec '25 revenue of ₹ 8.45 crore. This represent the growth of 21852% The revenue of Vista Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sun Pharma Advanced Research Company Ltd for the Mar '26 is ₹ 1775 crore as compare to the Dec '25 ebitda of ₹ -69 crore. This represent the decline of -2672% The ebitda of Vista Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sun Pharma Advanced Research Company Ltd changed from ₹ -95.9 crore to ₹ 1761 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Vista Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Sun Pharma Advanced Research Company Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vista Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
The Company works on innovation and new product development for global markets.
They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Limited was incorporated on March 1, 2006 as an innovative and development company.
It commenced operations on March 22, 2006.
As per Scheme of Arrangement, the entire business undertaking of the Innovative Research & Development including Novel Drug Delivery System (NDDS) Division of Sun Pharmaceuticals Industries' Research & Development Undertaking was transferred and vested into the Company effective from February 28, 2007.

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & had obtained Certificate of Commencement of Business on February 7, 1991.
The Company is engaged in the formulation of pharmaceutical products.
It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India. The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.
Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.

FAQs for the comparison of Sun Pharma Advanced Research Company Ltd and Vista Pharmaceuticals Ltd

Which company has a larger market capitalization, Sun Pharma Advanced Research Company Ltd or Vista Pharmaceuticals Ltd?

Market cap of Sun Pharma Advanced Research Company Ltd is 5,262 Cr while Market cap of Vista Pharmaceuticals Ltd is 44 Cr

What are the key factors driving the stock performance of Sun Pharma Advanced Research Company Ltd and Vista Pharmaceuticals Ltd?

The stock performance of Sun Pharma Advanced Research Company Ltd and Vista Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sun Pharma Advanced Research Company Ltd and Vista Pharmaceuticals Ltd?

As of May 18, 2026, the Sun Pharma Advanced Research Company Ltd stock price is INR ₹162.15. On the other hand, Vista Pharmaceuticals Ltd stock price is INR ₹7.26.

How do dividend payouts of Sun Pharma Advanced Research Company Ltd and Vista Pharmaceuticals Ltd compare?

To compare the dividend payouts of Sun Pharma Advanced Research Company Ltd and Vista Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.